Literature DB >> 15110653

Improved outcome of polyoma virus allograft nephropathy with early biopsy.

C B Drachenberg1, J C Papadimitriou, R Wali, J Nogueira, S Mendley, H H Hirsch, C B Cangro, D K Klassen, M R Weir, S T Bartlett, E Ramos.   

Abstract

Polyoma virus allograft nephropathy often results in accelerated graft loss despite reduction of immunosuppression and/or treatment with antiviral agents. Irreversible renal fibrosis due to late diagnosis is likely to be one of the important causes of treatment failure. Early biopsy in 14 patients resulted in stable graft function after a mean follow-up of 22 months.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110653     DOI: 10.1016/j.transproceed.2004.03.040

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  11 in total

1.  Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.

Authors:  Thurid Ahlenstiel-Grunow; Lars Pape
Journal:  Pediatr Nephrol       Date:  2018-12-11       Impact factor: 3.714

2.  LT, VP1 and TCR-BKV sequence analysis in a patient with post-transplant BKV nephropathy associated with EBV-related PTLD.

Authors:  Luis Rubio; Francisco J Vera-Sempere; María J Moreno-Baylach; Ana García; Isabel Zamora; José Simón
Journal:  Pediatr Nephrol       Date:  2005-07-27       Impact factor: 3.714

Review 3.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

4.  Bright Field Microscopy to Detect Decoy Cells Due to BK Virus Infection in the Fresh and Unstained Urine Sediment in Kidney Allograft Recipients.

Authors:  José A T Poloni; Gabriel G Pinto; Maria S B Giordani; Elizete Keitel; Nadiana Inocente; Carlos F Voegeli; Giovanni B Fogazzi; Alessandro C Pasqualotto; Liane N Rotta
Journal:  J Clin Lab Anal       Date:  2016-04-28       Impact factor: 2.352

5.  Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study.

Authors:  Xiaoli L Pang; Karen Doucette; Barbara LeBlanc; Sandra M Cockfield; Jutta K Preiksaitis
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

6.  Presence of urinary Haufen accurately predicts polyomavirus nephropathy.

Authors:  Harsharan K Singh; Kenneth A Andreoni; Victoria Madden; Karin True; Randal Detwiler; Karen Weck; Volker Nickeleit
Journal:  J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 10.121

7.  Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology.

Authors:  Rainer Gosert; Christine H Rinaldo; Georg A Funk; Adrian Egli; Emilio Ramos; Cinthia B Drachenberg; Hans H Hirsch
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

8.  Risk factors for polyoma virus nephropathy.

Authors:  Olivier Prince; Spasenija Savic; Michael Dickenmann; Jürg Steiger; Lukas Bubendorf; Michael J Mihatsch
Journal:  Nephrol Dial Transplant       Date:  2008-12-10       Impact factor: 5.992

9.  BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.

Authors:  H H Hirsch; K Yakhontova; M Lu; J Manzetti
Journal:  Am J Transplant       Date:  2015-12-07       Impact factor: 8.086

10.  Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia.

Authors:  Marwan M Azar; Roland Assi; Aziz K Valika; David B Banach; Isaac E Hall; Marie-Louise Landry; Maricar F Malinis
Journal:  World J Transplant       Date:  2017-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.